Companies / Vietnam

Vinapharm Wary Of Increased Competition

September 2006 | Company Spotlight

Printable version
Bookmark

Vinapharm is Vietnam's largest state-owned company, which owns all of the state-owned pharmaceutical-producing units.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Development Of Rotavirus Vaccine A Positive Move

Industry / Vietnam BMI View: The local production of vaccines in Vietnam will allow for their increased consumption due to improving affordability. However, over the medium term, BMI believes that the focus of Vietnamese...

July 2011

Construction Of Danasome Factories Starts

Industry / Vietnam Vietnam's US$1.4bn pharmaceutical market is one of the most promising in the Asia Pacific region. Annual per-capita spending is low (US$16.13) and growth is high - BMI is forecasting a compound annual...

August 2009

Bird Flu Vaccine Trials Planned

Industry / Vietnam Endorsing Vietnam's budding reputation for biomedical R&D, a human trial of a vaccine for protection against avian influenza has been approved by the Ministry of Health. The study will recruit volunteers...

March 2008

Ampharco Receives Investment

Industry / Vietnam The goal of Vietnam Pharmaceutical Joint Stock Company (Ampharco) to export its products to the US and other foreign markets has received a boost after investment funds were received from Vietnam Equity...

February 2008

First EU GMP-Compliant Plant Opens

Companies / Vietnam In what could herald the beginning of a trend for Vietnam's pharmaceutical industry to target more developed markets for export growth, Vietnamese-German joint venture Stada Vietnam has opened the country's...

January 2008